Lincoln Pharma: Value and Growth Stocks

Aug 17, 2015

Lincoln Pharma looks like ready to trade higher. Its financials are improving and recently it has launched extended release oral suspension drugs which is cough syrup. It is a dividend paying company.
Promoters stake has increased by 3.88%.

Improved Credit rating in Nov, 2014. A3+.

PE=12.42.
PB=1.85.

CMP: Rs 127.



You Might Also Like

0 Comments

Like us on Facebook